Mice lacking SLAMF5 on platelets or T cells had reduced cerebral infiltration of CD4+ T-cells and reduced thrombolytic activity after experimental stroke, resulting in a reduction of neurological damage. The gene discussed is CD84; the disease is stroke disorder.